Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Fleurence, Julien
22  Ergebnisse:
Personensuche X
?
1

Potentiation of Anticancer Antibody Efficacy by Antineoplas.. 

JoVE : Cancer Research
Bahri, Meriem ; Fleurence, Julien ; Faraj, Sébastien... , 2019
Link: https://www.jove.com/t/5..
 
?
2

Impairing temozolomide resistance driven by glioma stem‐lik..:

Fleurence, Julien ; Bahri, Meriem ; Fougeray, Sophie...
International Journal of Cancer.  146 (2019)  2 - p. 424-438 , 2019
Link: https://doi.org/10.1002/..
 
?
3

TargetingO-Acetyl-GD2 Ganglioside for Cancer Immunotherapy:

Fleurence, Julien ; Fougeray, Sophie ; Bahri, Meriem...
Journal of Immunology Research.  2017 (2017)  - p. 1-16 , 2017
Link: https://doi.org/10.1155/..
 
?
4

Targeting and killing glioblastoma with monoclonal antibody..:

Fleurence, Julien ; Cochonneau, Denis ; Fougeray, Sophie...
Oncotarget.  7 (2016)  27 - p. 41172-41185 , 2016
Link: https://doi.org/10.18632..
 
?
5

Anti-Gb3 Monoclonal Antibody Inhibits Angiogenesis and Tumo..:

Desselle, Ariane ; Chaumette, Tanguy ; Gaugler, Marie-Hélène...
PLoS ONE.  7 (2012)  11 - p. e45423 , 2012
Link: https://doi.org/10.1371/..
 
?
6

Glypican-3-specific CAR T cells co-expressing IL15 and IL21..:

Batra, Sai A ; Rathi, Purva ; Guo, Linjie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10765595/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
7

Targeting-Acetyl-GD2 Ganglioside for Cancer Immunotherapy:

Fleurence, Julien ; Fougeray, Sophie ; Bahri, Meriem...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2013-11-541235.  , 2017
Link: https://inserm.hal.scien..
 
?
8

Ciblage du GD2-O-acétylé par un anticorps monoclonal dans l..:

Fleurence, Julien
http://www.theses.fr/2017NANT1007/document.  , 2017
Link: http://www.theses.fr/201..
 
?
9

Targeting-Acetyl-GD2 Ganglioside for Cancer Immunotherapy:

Fleurence, Julien ; Fougeray, Sophie ; Bahri, Meriem...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2013-11-541235.  , 2017
Link: https://inserm.hal.scien..
 
?
10

Targeting-Acetyl-GD2 Ganglioside for Cancer Immunotherapy:

Fleurence, Julien ; Fougeray, Sophie ; Bahri, Meriem...
info:eu-repo/semantics/altIdentifier/pmid/28154831.  , 2017
Link: https://www.hal.inserm.f..
 
?
11

Targeting-Acetyl-GD2 Ganglioside for Cancer Immunotherapy:

Fleurence, Julien ; Fougeray, Sophie ; Bahri, Meriem...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2013-11-541235.  , 2017
Link: https://inserm.hal.scien..
 
?
12

Targeting and killing glioblastoma with monoclonal antibody..:

Fleurence, Julien ; Cochonneau, Denis ; Fougeray, Sophie...
info:eu-repo/semantics/altIdentifier/pmid/27172791.  , 2016
Link: https://inserm.hal.scien..
 
?
13

O-acetylated gangliosides: Structure, biosynthesis, immunog..:

Fougeray, Sophie ; Fleurence, Julien ; Faraj, Sébastien...
info:eu-repo/semantics/altIdentifier/doi/10.14312/2052-4994.2016-5.  , 2016
Link: https://inserm.hal.scien..
 
?
14

Targeting and killing glioblastoma with monoclonal antibody..:

Fleurence, Julien ; Cochonneau, Denis ; Fougeray, Sophie...
info:eu-repo/semantics/altIdentifier/pmid/27172791.  , 2016
Link: https://inserm.hal.scien..
 
?
15

O-acetylated gangliosides: Structure, biosynthesis, immunog..:

Fougeray, Sophie ; Fleurence, Julien ; Faraj, Sébastien...
info:eu-repo/semantics/altIdentifier/doi/10.14312/2052-4994.2016-5.  , 2016
Link: https://www.hal.inserm.f..
 
1-15